Prospective Sample Collection for Cancer of Bladder
ConditionUrinary Bladder Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorUniversitaire Ziekenhuizen KU Leuven
About this trial
The goal of the Flemish Databank for Urothelial Cancer is to collect clinical and pathological data of patients treated for urothelial cancer (UC).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
who are aged between 18-90,
who are of male or female sex,
who give their informed consent to collect their clinical and pathological data,
who are planned to undergo TURBT for BC,
Disqualifiers
patients who do not give their informed consent to collect their clinical and pathological data,
patients who withdraw their informed consent to use their clinical and pathological data,
patients who refuse the planned treatment,
women who are pregnant or have suspicion of pregnancy.
Trial population
Patients treated at University Hospitals Leuven for urothelial cancer that fit the aforementioned inclusion and exclusion criteria.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 1 trial groupGroup A: UC patients
Trial outcomes
Primary outcomes
1
Progression to MIBC
Histopathologically proven muscle-invasive bladder cancer (at least T2 disease) in pathological evaluation of the TURBT specimen
Time frame
10 yearsSecondary outcomes
1
Recurrence of NMIBC
Clinically (cystoscopically and/or radiologically) proven re-occurence of non-muscle-invasive bladder cancer (Tis, Ta or T1 disease)
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Universitaire Ziekenhuizen KU Leuven
Lead sponsor
KU Leuven
Collaborator
Source ClinicalTrials.gov